Lupin Limited has informed the Exchange regarding a press release dated February 02, 2026, titled "Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases".
Lupin Limited has informed the Exchange regarding a press release dated February 02, 2026, titled "Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases".